Japanese maker of dental handpieces and precision dental/medical equipment used by dentists worldwide.
Japanese maker of dental handpieces and precision dental/medical equipment used by dentists worldwide.
Sells high-speed handpieces under the NSK name mainly through dental distributors, with overseas markets together bigger than Japan, and earns from repairs and replacement as handpieces wear out.
In one line: A dental-equipment specialist like a smaller Dentsply Sirona unit.
Moat: narrow (process know-how, brand). Precision micro-motor engineering and brand trust among dentists built over decades.
Headquarters: Tochigi, Japan · Founded: 1930 · Employees: 2,204
Size Nakanishi (7716.T) is a Japan Health Care company (Medical Specialties) with a market value of $1.78B, the 519th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥1,601 on 18 Nov 2026.
Performance Over six months the shares gained 7.0%, against +1.5% for the median peer and -1.4% for the Japan market (cap-weighted) — 9th highest of 20 in its peer set.
Growth Revenue grew 17.2% over the last twelve months (peer median +9.6%); the operating margin is 21.1% (peer median 12.7%).
Valuation It trades at 19.0× forward earnings against a peer median of 27.0× (6th cheapest of 18).
Price implies For today's price to make sense, revenue must grow about 5% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -15 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 6.3 points above its cost of capital (7.6% WACC).
Next results Next results expected around 11 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ¥92.8B | ¥81.2B | ¥77.0B | ¥59.7B | ¥48.7B |
| Revenue growth | — | +5% | +29% | +23% | — |
| Gross profit | ¥54.3B | ¥42.2B | ¥40.4B | ¥34.1B | ¥30.4B |
| EBITDA | ¥26.3B | ¥19.9B | ¥20.5B | ¥17.7B | ¥17.5B |
| Net income | ¥3.91B | -¥2.40B | ¥8.58B | ¥22.8B | ¥12.5B |
| Free cash flow | n/a | ¥12.3B | ¥10.5B | ¥2.93B | ¥4.29B |
| Capital expenditure | n/a | ¥5.31B | ¥5.25B | ¥5.95B | ¥3.98B |
| Total debt | ¥30.7B | ¥26.8B | ¥18.7B | ¥11.7B | ¥481M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Nakanishi 7716.T | $1.78B | +7% | +17% | 21% | 19.0× | 4.8% |
| DENTSPLY SIRONA XRAY | $1.69B | -13% | -1% | 5% | 6.8× | 11.2% |
| Morita 6455.T | $666M | -5% | 0% | 12% | 10.2× | -11.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 7716.T | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +13.6% | -5.0% | 4th highest of 21 |
| 6-month return | +7.0% | +1.5% | 9th highest of 20 |
| Distance from 52-week high | -5.4% | -24.8% | 2nd highest of 21 |
| Revenue growth (TTM) | +17.2% | +9.6% | 9th highest of 21 |
| Operating margin | 21.1% | 12.7% | 3rd highest of 21 |
| Forward P/E | 19.0× | 27.0× | 6th cheapest of 18 |
| Growth the price implies (Req g, 7 yrs) | 4.8% | 13.8% | 5th least demanding of 14 |
| Growth delivered (Del g) | +19.7% | +12.7% | 4th highest of 14 |
| Hurdle (Req g minus delivered) | -14.9 pp | -0.3 pp | 2nd least demanding of 14 |
| ROIC minus cost of capital | +6.3 pp | -0.6 pp | 7th highest of 21 |
| EV / EBITDA | 10.0× | 16.8× | 5th cheapest of 15 |
| Net debt / EBITDA | -0.8× | -0.7× | 8th least indebted of 16 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Nakanishi 7716.T | Japan | $1.78B | +7% | +17% | 21% | 19.0× | 4.8% | +19.7% |
| ChemoMetec A/S CHEMM.CO | Denmark | $1.77B | +107% | +3% | 49% | 46.7× | 19.4% | +12.7% |
| Poly Medicure POLYMED.NS | India | $1.79B | +14% | +25% | 16% | 39.9× | n/a | n/a |
| Shandong Weigao Group Medical Polymer 1066.HK | Hong Kong | $1.82B | -8% | +7% | 14% | 8.2× | -12.6% | +2.1% |
| LeMaitre Vascular LMAT | United States | $1.73B | -25% | +12% | 28% | 24.5× | 2.9% | +14.0% |
| Fukuda Denshi 6960.T | Japan | $1.84B | +4% | 0% | 19% | 15.4× | -1.6% | -1.0% |
| Mehow Innovative 301363.SZ | China | $1.72B | -36% | +10% | 21% | 34.2× | 16.4% | +12.9% |
| Rigaku 268A.T | Japan | $1.85B | -54% | +9% | 16% | 23.1× | 18.3% | +14.5% |
| Embla Medical hf EMBLA.CO | Denmark | $1.72B | +1% | +6% | 14% | 17.2× | -1.9% | +8.3% |
| Molbio Diagnostics MOLBIO.NS | India | $1.85B | n/a | +35% | 17% | n/a | n/a | n/a |
| SKAN SKAN.SW | Switzerland | $1.85B | +40% | +9% | 11% | 49.5× | 13.8% | +11.7% |
| Medartis MED.SW | Switzerland | $1.86B | +47% | +30% | 2% | 72.8× | n/a | n/a |
| DENTSPLY SIRONA XRAY | United States | $1.69B | -13% | -1% | 5% | 6.8× | 11.2% | +1.9% |
| Kestra Medical Technologies KMTS | United States | $1.69B | +36% | +61% | -134% | n/a | n/a | n/a |
| Inspire Medical Systems INSP | United States | $1.68B | +32% | 0% | 2% | 41.3× | 28.7% | +51.2% |
| NIPRO 8086.T | Japan | $1.68B | -11% | +5% | 5% | 15.8× | n/a | n/a |
| Butterfly Network BFLY | United States | $1.63B | +38% | +39% | -36% | n/a | n/a | n/a |
| Angelalign Technology 6699.HK | Hong Kong | $1.62B | -8% | +84% | 9% | 52.5× | 16.7% | +25.8% |
| Cofoe Medical Technology 301087.SZ | China | $1.60B | -6% | +33% | 10% | 25.1× | 11.2% | +7.4% |
| Wuxi Unicomp Technology 688531.SS | China | $1.58B | -49% | +53% | 12% | 35.8× | n/a | n/a |
| Vitrolife VITR.ST | Sweden | $1.57B | +13% | -2% | 19% | 27.0× | 22.2% | +22.5% |